Increased remnant lipoprotein in patients with coronary artery disease - Evaluation utilizing a newly developed remnant assay, remnant lipoproteins cholesterol homogeneous assay (RemL-C)

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 2, 2007, Pages 56-64

  Nakada, Yoshinobu ^a   Kurosawa, Hideo ^a   Tohyama, Jun Ichiro ^a   Inoue, Yae ^a   Ikewaki, Katsunori ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery disease; Lipoprotein; RemL C; Remnant

Indexed keywords

BIOLOGICAL MARKER; CHYLOMICRON REMNANT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIPOPROTEIN; PHOSPHOLIPASE D; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AGE; AGED; ARTICLE; BALLOON DILATATION; BIOASSAY; BLOOD; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; RISK FACTOR;

AGE FACTORS; AGED; BALLOON DILATATION; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; CHYLOMICRON REMNANTS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIPOPROTEINS; MALE; MIDDLE AGED; PHOSPHOLIPASE D; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34250654920     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.14.56     Document Type: Article

References (25)

1. Havel RJ: Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol, 1994; 5:102-109
2. Mahley RW, Huang Y, and Rall SC, Jr.: Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res, 1999; 40:1933-1949
3. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Nakamura H, and Campos E: Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta, 1993; 223:53-71
4. Miyauchi K, Kayahara N, Mori H, Sugiuchi H, and Irie T: Development of homogeneous assay for measuring remnant-like particles cholesterol in serum. Clin Chem, 2005; 51:A129
5. Miyauchi K, Kuwata H, Sugiuchi H, Irie T, Ishigami M, Yasmashita S, and Yamamura T: Development of a direct remnant lipoprotein cholesterol determination assay using detergent. Jap J Clin Chem, 2005; 34:325
6. Miida T, Nakamura Y, Mezaki T, Hanyu O, Maruyama S, Horikawa Y, Izawa S, Yamada Y, Matsui H, and Okada M: LDL-cholesterol and HDL-cholesterol concentrations decrease during the day. Ann Clin Biochem, 2002; 39:241-249
7. Friedewald WT, Levy RI, and Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18:499-502
8. Hirowatari Y, Yoshida H, Kurosawa H, Doumitu KI, and Tada N: Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. J Lipid Res, 2003; 44:1404-1412
9. Rifai N, Tracy RP, and Ridker PM: Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clinical Chemistry, 1999; 45:2136-2141
10. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, and Simes R: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005; 366:1267-1278
11. Hokanson JE and Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk, 1996; 3:213-219
12. Kawakami A and Yoshida M: Remnant lipoproteins and atherogenesis. J Atheroscler Thromb, 2005; 12:73-76
13. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PW, Ordovas JM, and Schaefer EJ: Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis, 2001; 154:229-236
14. Nakamura T and Kugiyama K: Triglycerides and remnant particles as risk factors for coronary artery disease. Curr Atheroscler Rep, 2006; 8:107-110
15. Masuoka H, Kamei S, Ozaki M, Kawasaki A, Shintani U, Ito M, and Nakano T. Predictive value of remnant-like particle cholesterol as an indicator of coronary artery stenosis in patients with normal serum triglyceride levels. Intern Med, 2000; 39:540-546
16. Masuoka H, Ishikura K, Kamei S, Obe T, Seko T, Okuda K, Koyabu S, Tsuneoka K, Tamai T, Sugawa M, and Nakano T: Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease. Am Heart J, 1998; 136:226-230
17. Pearson TA, Bulkley BH, Achuff SC, Kwiterovich PO, and Gordis L: The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol, 1979; 109:285-295
18. Wang XL, Tam C, McCredie RM, and Wilcken DE: Determinants of severity of coronary artery disease in Australian men and women. Circulation, 1994; 89:1974-1981
19. Welch G and Loscalzo J: Mechanism of disease: homocysteine and atherosclerosis. N Engl J Med, 1998; 338:1042-1050
20. Frauscher G, Karnaukhova E, Muehl A, Hoeger H, and Lubec B: Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine induced endothelial damage? Life Sci, 1995; 57:813-817
21. Mansoor MA, Seljeflot I, Arnesen H, Knudsen A, Bates CJ, Mishra G, and Larsen TW: Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia. Clin Biochem, 2004; 37:408-414
22. Libby P, Ridker PM, and Maseri A: Inflammation and atherosclerosis. Circulation, 2002; 105:1135-1143
23. Rifai N and Ridker PM: Inflammatory markers and coronary heart disease. Curr Opin Lipidol, 2002; 13:383-389
24. Matsuzawa Y, Funahashi T, Kihara S, and Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol, 2004; 24:29-33
25. Wu JT and Wu LL: Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment. Clin Chim Acta, 2006; 366:74-80